$ELTP·4

ELITE PHARMACEUTICALS INC /NV/ · Jun 4, 4:07 PM ET

ELITE PHARMACEUTICALS INC /NV/ 4

4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Jun 4, 2015

Insider Transaction Report

Form 4
Period: 2015-06-02
Hakim Nasrat A
DirectorPresident & CEO
Transactions
  • Conversion

    Warrants

    2015-06-021,982,1060 total(indirect: By LLC)
    Exercise: $0.06From: 2011-03-31Exp: 2018-03-31Common Stock (1,982,106 underlying)
  • Conversion

    Common Stock

    2015-06-02$0.06/sh+2,741,801$171,3635,311,819 total(indirect: By LLC)
  • Conversion

    Warrants

    2015-06-02759,6950 total(indirect: By LLC)
    Exercise: $0.06From: 2009-10-30Exp: 2016-10-30Common Stock (759,695 underlying)
Holdings
  • Common Stock

    (indirect: By IRA)
    2,700,000
  • Common Stock

    13,760,695

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT